Briviact 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FQ2NK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,424
Award facts
- Contract value 100% obligated
- $3,423.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,423.68 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count supply) on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a prime contract valued at $999,999,999.00 and extending through December 2026.
The Briviact supply supports the Defense Logistics Agency's medical supply chain operations, which serve military and veteran healthcare systems globally. AmerisourceBergen Drug Corp's comprehensive IDC vehicle enables the delivery of a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The company's track record of fulfilling federal medical procurement requirements through open competition, combined with its established presence as a critical vendor for military healthcare procurement, positions it as a key supplier within the DLA's pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DB25FQ2NK?
SPE2DB25FQ2NK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FQ2NK worth?
The government has obligated $3,424 on SPE2DB25FQ2NK.
Is contract SPE2DB25FQ2NK an order under another contract?
Yes. SPE2DB25FQ2NK is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2NK competed?
The extent of competition for SPE2DB25FQ2NK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award